US Stock MarketDetailed Quotes

RYTM Rhythm Pharmaceuticals

Watchlist
  • 59.030
  • -0.330-0.56%
Close Nov 21 16:00 ET
  • 59.030
  • 0.0000.00%
Post 16:20 ET
3.63BMarket Cap-13664P/E (TTM)

Rhythm Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rhythm Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
32.47M
33.25M
+785.38K
Beat Est.
+44.27%
+47.76%
+2.42%
EPS
-0.81
-0.73
+0.08
Beat Est.
-6.15%
+3.95%
+9.50%
Analyst Rating
Strong Buy

Nov 21, 2024

Rhythm Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 38.348M--
--2024/Q4-- / 35.926M--
Nov 5, 20242024/Q333.251M / 32.466M--
Aug 6, 20242024/Q229.078M / 28.790M--
May 7, 20242024/Q125.967M / 26.896M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 38.348M--
--2024/Q4-- / 35.926M--
Nov 5, 20242024/Q333.251M / 32.466M--
Aug 6, 20242024/Q229.078M / 28.790M--
May 7, 20242024/Q125.967M / 26.896M--

Unlock Free Earnings Estimates

Rhythm Pharmaceuticals Earnings Reports

  • Rhythm Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 6 08:22 ET

  • Rhythm Pharmaceuticals | 8-K: Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update

    Nov 5 16:06 ET

  • Rhythm Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Aug 14 16:34 ET

  • Rhythm Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:27 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      9.09%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data